Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01138527 · ClinicalTrials.gov registry record
Prostate Cancer Localization With a Multiparametric Magnetic Resonance (MR) Approach
A clinical trial, sponsored by Radboud University Medical Center.
- Completed
- Registry status
- 148
- Enrollment target
NCT01138527: Completed study, sponsored by Radboud University Medical Center.
NCT01138527 is a clinical trial that has completed, run by Radboud University Medical Center. The registered enrollment target is 148 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01138527 has completed, sponsored by Radboud University Medical Center.
- COMPLETED
- Registry status
- 148 participants
- Enrollment target
Study Summary
The primary objective of this prospective multi-centre study is to prove the diagnostic accuracy of in vivo 3T multi-modality Magnetic Resonance Imaging (high resolution T2-weighted MRI, DCE-MRI, MRSI and DWI techniques) in distinguishing carcinoma from other prostate tissue. The gold standard for distinguishing the tissue types is the analysis of whole-mount sections of the resected prostate by a genitourinary histopathologist.
Interventions
- OTHER MRI examination
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 148 participants |
| Start Date | 2010-06 |
| Est. Completion | 2019-07 |
What the finished NCT01138527 record still lists
NCT01138527 is an observational study that tracks outcomes without assigning an intervention. The registered 148 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which MRI examination is the first listed.
NCT01138527 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01138527 about?
NCT01138527 is a clinical study titled "Prostate Cancer Localization With a Multiparametric Magnetic Resonance (MR) Approach". The primary objective of this prospective multi-centre study is to prove the diagnostic accuracy of in vivo 3T multi-modality Magnetic Resonance Imaging (high resolution T2-weighted MRI, DCE-MRI, MRSI and DWI techniques) in distinguishing carcinoma from other prostate tissue. The gold standard for d...
What is the current status of trial NCT01138527?
This trial is currently completed. The enrollment target is 148 participants. The study started on 2010-06. Estimated completion is 2019-07.
What interventions are being tested in trial NCT01138527?
The interventions under investigation include: MRI examination (OTHER).
Who is sponsoring clinical trial NCT01138527?
This trial is sponsored by Radboud University Medical Center, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00739362 · 148 participants · Phase 2
Effects of Brain Stimulation on Food Intake and Behavioral Weight Loss Treatment
- NCT03161223 · 148 participants · Phase 1
Durvalumab in Different Combinations With Pralatrexate, Romidepsin and Oral 5-Azacitidine for Lymphoma
- NCT03858231 · 148 participants · Phase 4
Opioids Versus Non-Opioids Postoperative After Knee Arthroscopic Surgery
- NCT04486352 · 148 participants · Phase 1
A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia